Peyronie's disease in a patient after COVID-19 infection: A case report.
Andrologia
; 53(11): e14219, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1358562
ABSTRACT
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by a novel coronavirus (SARS-CoV-2), which demonstrates the ability to invade endothelial cells and cause systemic inflammation. Many possible long-term sequelae of COVID-19 remain unidentified. We describe a case of a man who developed Peyronie's disease after a resolved COVID-19 infection. Erectile dysfunction was confirmed by the International Index of Erectile Function-15(IIEF) and Sexual Health Inventory for Men(SHIM) scores. A diagnosis was Peyronie's disease was confirmed on ultrasound. Furthermore, he was found to have low endothelial progenitor cells colony-forming units and low brachial artery flow-mediated vasodilation, both of that are indicative of endothelial dysfunction. This case suggests Peyronie's disease should be considered as a possible sequela of COVID-19 infection and providers should inquire about a history of COVID-19 infection in patients presenting with Peyronie's disease.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Penile Induration
/
COVID-19
/
Erectile Dysfunction
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Male
Language:
English
Journal:
Andrologia
Year:
2021
Document Type:
Article
Affiliation country:
And.14219
Similar
MEDLINE
...
LILACS
LIS